0001654954-16-003646.txt : 20161109 0001654954-16-003646.hdr.sgml : 20161109 20161108202205 ACCESSION NUMBER: 0001654954-16-003646 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20161109 DATE AS OF CHANGE: 20161108 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Venaxis, Inc. CENTRAL INDEX KEY: 0001167419 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 841553387 STATE OF INCORPORATION: CO FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-79102 FILM NUMBER: 161982565 BUSINESS ADDRESS: STREET 1: 1585 S. PERRY STREET CITY: CASTLE ROCK STATE: CO ZIP: 80104 BUSINESS PHONE: (303) 794-2000 MAIL ADDRESS: STREET 1: 1585 S. PERRY STREET CITY: CASTLE ROCK STATE: CO ZIP: 80104 FORMER COMPANY: FORMER CONFORMED NAME: AspenBio Pharma, Inc. DATE OF NAME CHANGE: 20051110 FORMER COMPANY: FORMER CONFORMED NAME: ASPENBIO INC DATE OF NAME CHANGE: 20020213 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Honig Barry C CENTRAL INDEX KEY: 0001373203 FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: 595 S FEDERAL HIGHWAY STREET 2: SUITE 600 CITY: BOCA RATON STATE: FL ZIP: 33432 FORMER COMPANY: FORMER CONFORMED NAME: Honig Barry R DATE OF NAME CHANGE: 20060818 SC 13D/A 1 honig13da-am3_venaxisnov2.htm SCHEDULE 13D/A honig13da-am3_venaxisnov82016

 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
SCHEDULE 13D/A
Amendment No.3
 (Rule 13d-101)
 
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
RULE 13d-2(a)
 
VENAXIS, INC.
(Name of Issuer)
 
Common Stock, no par value
(Title of Class of Securities)
 
92262A206
(CUSIP Number)
 
Barry Honig
555 South Federal Highway #450
Boca Raton, FL 33432
 
Copy To:
Sichenzia Ross Ference Kesner LLP
Harvey Kesner, Esq.
61 Broadway, 32nd Floor
New York, NY 10006
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
 
November 8, 2016
(Date of Event which Requires Filing of this Statement)
 
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. [X]
 
Note:  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See § 240.13d-7 for other parties to whom copies are to be sent.
 
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
 
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 

 
 
 
 
CUSIP No. 92262A206
 
 
1
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Barry Honig
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)  [  ]
(b)  [  ]
3
SEC USE ONLY
  
4
SOURCE OF FUNDS (See Instructions)
PF
 
5
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
[   ]
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7
SOLE VOTING POWER:
 
0
 
 
8
SHARED VOTING POWER:
 
452,585 (1)
 
 
9
SOLE DISPOSITIVE POWER:
 
0
 
 
10
SHARED DISPOSITIVE POWER:
452,585 (1)
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
452,585 (1)
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
[_]
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
10.05% (based on 4,503,971 shares of common stock outstanding as of September 22, 2016)
 
14
TYPE OF REPORTING PERSON (See Instructions)
IN
 
(1)  Includes (i) 439,185 shares of common stock held by GRQ Consultants, Inc. 401K (“401K”) and (ii) 13,400 shares of common stock held by GRQ Consultants, Inc. Roth 401K FBO Barry Honig (“Roth 401K”). Mr. Honig is the trustee of 401K and Roth 401K in such capacity holds voting and dispositive power over the securities held by such entities.
 
 
 
 
 
 
 
CUSIP No. 92262A206
 
 
1
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
GRQ Consultants, Inc. 401K
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)  [  ]
(b)  [  ]
3
SEC USE ONLY
  
4
SOURCE OF FUNDS (See Instructions)
WC
 
5
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
[   ]
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
Florida
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7
SOLE VOTING POWER:
 
0
 
 
8
SHARED VOTING POWER:
 
439,185 (1)
 
 
9
SOLE DISPOSITIVE POWER:
 
0
 
 
10
SHARED DISPOSITIVE POWER:
439,185 (1)
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
439,185 (1)
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
[_]
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
9.75% (based on 4,503,971shares of common stock outstanding as of September 22, 2016)
 
14
TYPE OF REPORTING PERSON (See Instructions)
OO
 
(1) Mr. Honig is the trustee of 401K and in such capacity holds voting and dispositive power over the securities held by 401K.
 
 
 
 
 
CUSIP No. 92262A206
 
 
1
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
GRQ Consultants, Inc. Roth 401K FBO Barry Honig
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)  [  ]
(b)  [  ]
3
SEC USE ONLY
  
4
SOURCE OF FUNDS (See Instructions)
WC
 
5
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
[   ]
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
Florida
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7
SOLE VOTING POWER:
 
0
 
 
8
SHARED VOTING POWER:
 
13,400 (1)
 
 
9
SOLE DISPOSITIVE POWER:
 
0
 
 
10
SHARED DISPOSITIVE POWER:
13,400 (1)
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
13,400 (1)
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
[_]
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.30% (based on 4,503,971shares of common stock outstanding as of September 22, 2016)
 
14
TYPE OF REPORTING PERSON (See Instructions)
OO
 
(1) Mr. Honig is the trustee of Roth 401K and in such capacity holds voting and dispositive power over the securities held by Roth 401K.
 
 
 
 
 
Item 1.   Security and Issuer
 
The title and class of equity securities to which this Schedule 13D relates is common stock, no par value, of Venaxis, Inc., a Colorado corporation (the "Issuer"). The address of the principal executive offices of the Issuer is 1585 S. Perry Street, Castle Rock, CO 80104.
 
Item 2.   Identity and Background
 
(a) This statement is filed on behalf of Barry Honig, 401K and Roth 401K (collectively the “Reporting Person”).
 
(b) The Reporting Person’s address is 555 South Federal Highway, #450, Boca Raton, FL 33432.
 
(c) Not applicable.
 
(d) During the last five years, the Reporting Person has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
 
(e) During the last five years, the Reporting Person has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result thereof was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
 
(f) The Reporting Person is a citizen of the United States and the State of Florida.
 
Item 3.   Source and Amount of Funds or Other Considerations
 
All shares were purchased with the Reporting Person’s personal funds or working capital.
 
Item 4.   Purpose of Transaction
 
All of the Issuer’s securities owned by the Reporting Person have been acquired for investment purposes only.  Except as set forth herein and in Schedule 13D filed with the Securities and Exchange Commission (the “Commission”) on September 8, 2016, Amendment no. 1 filed with the Commission on September 13, 2016 and Amendment no. 2 filed with the Commission on September 14, 2016, the Reporting Person has no present plans or proposals that relate to or would result in any of the actions required to be described in subsections (a) through (j) of Item 4 of Schedule 13D.  The Reporting Person may, at any time, review or reconsider their positions with respect to the Issuer and formulate plans or proposals with respect to any of such matters, but has no present intention of doing so.
 
The Reporting Person may engage in discussions with management and security holders of the Issuer and other persons with respect to the subject class of securities, the Issuer, the Issuer’s industry, business, condition, operations, structure, governance, management, capitalization, policies, plans, and prospects and related and other matters. In particular, the Reporting Person may engage in discussions with management and security holders of the Issuer regarding the complexion of the Issuer’s board of directors and options for increasing shareholder value. The Reporting Person plans and proposes to review and analyze such Reporting Person’s interest in the Issuer on a continuing basis and may engage in such discussions, as well as discussions with the Issuer, the Issuer’s directors and officers and other persons related to the Issuer, as the Reporting Person deems necessary or appropriate in connection with the Reporting Person’s interest in the Issuer.
 
Depending upon the factors described below and any other factor that is or becomes relevant, the Reporting Person plans and proposes to: (a) acquire additional amounts of the subject class of securities or different equity, debt, or other securities of the Issuer, derivative securities related to securities of the Issuer or other securities related to the Issuer (collectively, “Issuer-Related Securities”) or a combination or combinations of Issuer-Related Securities, including by purchase or other method, pursuant to open market, private, tender offer, or other transactions, using borrowed or other funds or consideration of or from any source described herein or other source or via a combination or combinations of such methods, transactions, consideration, and sources; (b) dispose of all or part of the securities covered by this statement and any other Issuer- Related Securities, including by sale or other method, pursuant to open market, private, or other transactions or via a combination or combinations of such methods and transactions; (c) engage in financing, lending, hedging, pledging, or similar transactions involving the securities covered by this statement or other Issuer-Related Securities or a combination or combinations of such transactions; (d) engage in discussions and otherwise communicate with the Issuer, officers, directors, and security holders of the Issuer and other persons related to the Issuer with respect to Issuer-Related Securities, the Issuer, the Issuer’s industry, business, condition, operations, structure, governance, management, capitalization, dividend policy, other policies, plans, and prospects and related and other matters; (e) suggest or recommend a transaction or transactions involving the acquisition, sale, or exchange of all or part of the Issuer-Related Securities or assets of the Issuer, other actions or a combination or combinations of such actions, in any case, which relates or relate to (or could result in) a change or changes to the Issuer’s business, condition, operations, structure, governance, management, capitalization, policies, plans, and prospects and similar and other actions and changes; (f) make a proposal or proposals involving the acquisition or sale of all or part of the Issuer-Related Securities or assets of the Issuer; (g) make a proposal or proposals to request that the Issuer and/or the security holders of the Issuer consider an extraordinary or other transaction, such as a merger or reorganization, or a combination or combinations of such transactions; and (h) engage in a combination or combinations of the foregoing plans and/or proposals.
 
 
 
 
Each such plan or proposal may be subject to, and depend upon, a variety of factors, including (i) current and anticipated trading prices and the expected value of applicable Issuer-Related Securities, (ii) the Issuer’s financial condition and position, results of operations, plans, prospects and strategies, (iii) general industry conditions, (iv) the availability, form and terms of financing and other investment and business opportunities, (v) general stock market and economic conditions, (vi) tax considerations and (vii) other factors. Each acquisition, disposition, transaction, discussion, communication, suggestion, recommendation, proposal and other action described herein may be effected, made or taken, as applicable, at any time and/or from time to time without prior notice. Although the plans and proposals described herein reflect the plans and proposals presently contemplated by the Reporting Person with respect to the Issuer and the Issuer-Related Securities, as applicable, each such plan and proposal is subject to change at any time and from time to time dependent upon contingencies and assumed and speculative conditions and other factors, including actions taken by the Issuer, the Issuer’s board of directors, other security holders of the Issuer and other parties and the outcome of the discussions, communications, transactions and other actions described herein. There can be no assurance that any such plan or proposal will be consummated or pursued or result in any transaction described herein or other transaction or that any action contemplated by any such plan or proposal (or any similar action) will be taken.
 
Item 5.   Interest in Securities of the Issuer
 
(a)  
Mr. Honig beneficially owns 439,185 shares of common stock held by 401K and 13,400 shares of common stock held by Roth 401K, or an aggregate of 10.05% of the Issuer’s common stock. Mr. Honig is the trustee of 401K and Roth 401K, and, in such capacity, has voting and dispositive power over the securities held by such entities.
 
(b)  
Mr. Honig may be deemed to hold sole voting and dispositive power over 0 shares of common stock of the Issuer and shares voting and dispositive power over 452,585 shares of common stock.  401K may be deemed to hold shared voting and dispositive power over 439,185 shares of the Issuer’s common stock and Roth 401K may be deemed to hold shared voting and dispositive power over 13,400 shares of the Issuer’s common stock.
 
(c) 
On September 12, 2016, 401K purchased 9,000 shares of the Issuer’s common stock at a purchase price of $4.14 per share.
 
On September 30, 2016, 401K purchased 2,228 shares of the Issuer’s common stock at a purchase price of $2.80 per share.
 
On October 6, 2016, 401K purchased 12,777 shares of the Issuer’s common stock at a purchase price of $2.71 per share.
 
On October 13, 2016, 401K purchased 28,935 shares of the Issuer’s common stock at a purchase price of $2.28 per share.
 
On October 18, 2016, Roth 401K purchased 13,400 shares of the Issuer’s common stock at a purchase price of $2.68 per share.
 
On October 19, 2016, 401K purchased 6,086 shares of the Issuer’s common stock at a purchase price of $2.78 per share.
 
(d)
To the best knowledge of the Reporting Person, except as set forth in this Schedule 13D, no person other than the Reporting Person has the right to receive, or the power to direct the receipt of, dividends from, or the proceeds from the sale of the 439,185 shares of common stock reported in Item 5(a).

(e)
Not applicable.
 
Item 6.   Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer
 
Other than as described herein, there are no contracts, arrangements, understandings or relationships (legal or otherwise) between the Reporting Person and any other person with respect to the shares.
 
Item 7.   Material to Be Filed as Exhibits
 
 

Exhibit Number
 
Description
 
 
 
 
  99.1 
Joint Filing Agreement with GRQ Consultants, Inc. 401K and GRQ Consultants, Inc. Roth 401K FBO Barry Honig
 
 
 
 
 
SIGNATURE
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
Dated: November 8, 2016
 
/s/ Barry Honig
 
 
 
Barry Honig
 
 
 
Dated: November 8, 2016
 
GRQ CONSULTANTS, INC. 401K
 
 
 
 
 
 
By:
/s/ Barry Honig
 
 
 
Barry Honig
Trustee
 
 
Dated: November 8, 2016
 
GRQ CONSULTANTS, INC. ROTH 401K
 
 
 
FBO BARRY HONIG
 
 
 
By:
/s/ Barry Honig
 
 
 
Barry Honig
Trustee
 
 
 
 
 
EX-99.1 2 ex99-1.htm JOINT FILING AGREEMENT WITH GRQ CONSULTANTS, INC. 401K AND GRQ CONSULTANTS, INC. ROTH 401K FBO BARRY HONIG Blueprint
 
Exhibit 99.1
 
AGREEMENT TO FILE JOINT SCHEDULE 13D
 
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby consent to the joint filing on their behalf of a single Schedule 13D and any amendments thereto, with respect to the beneficial ownership by each of the undersigned of shares of the common stock of Venaxis, Inc., a Colorado corporation.  The undersigned hereby further agree that this statement may be executed in any number of counterparts, each of which when so executed shall be deemed to be an original, but all of which counterparts shall together constitute one and the same instrument.
 
Dated: November 8, 2016
 
/s/ Barry Honig
 
 
 
Barry Honig
 
 
 
Dated: November 8, 2016
 
GRQ CONSULTANTS, INC. 401K
 
 
 
 
 
 
By:
/s/ Barry Honig
 
 
 
Barry Honig
Trustee
 
 
 
Dated: November 8, 2016
 
GRQ CONSULTANTS, INC. ROTH 401K
 
 
 
FBO BARRY HONIG
 
 
 
By:
/s/ Barry Honig
 
 
 
Barry Honig
Trustee